Teleflex finalizes acquisition of Biotronik's business
07/02/25, 7:37 PM
Location
wayne
berlinIndustry
biotechnology
health care
medical device
medical
manufacturing
Teleflex has completed the acquisition of Biotronik's vascular intervention business for $895 million. This acquisition enables Teleflex to enhance its clinical trial program and expand its innovative product offerings in the cath lab. The deal aims to improve patient care and strengthen Teleflex's global presence. The completion was announced earlier than expected by Teleflex's CEO, Liam Kelly.
Company Info
Location
Wayne, Pennsylvania, United States
Company info
Teleflex is a global provider of medical technologies designed to improve the health and quality of people's lives. The company specializes in vascular intervention, surgical instruments, and anesthesia technologies. Teleflex is committed to investing in innovative solutions to enhance patient care and outcomes. They operate in numerous markets worldwide.
Related People
Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Th
Th • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more
Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Ah
Ah • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more